Company: CDLX
Filing Date: 2025-04-03
Form Type: ARS
Source: 0001666071-25-000048
Chunk: 169

Company: Cardlytics, Inc.
Filing Date: 2025-04-03
Form: ARS
Chunk 169
---
/2025 10.32 Amended Non-Employee Director Compensation Plan 10-K 001-38386 10.53 3/14/2025 10.33 Work Order between the Company and American Express Travel Related Services Company dated March 14, 2024 to Master Hosted Services Agreement 10-Q 001-38386 10.4 5/8/2024 10.34^ Statement of Work Change Order dated May 24, 2024, between the Registrant and Bank of America, N.A. 10-Q 001-38386 10.1 8/7/2024 10.35 Offer Letter between Amit Gupta and the Registrant, dated August 21, 2024. 10-Q 001-38386 10.1 11/6/2024 10.36 Amended and Restated Loan and Security Agreement dated as of September 30, 2024, by and among Cardlytics, Inc., as Borrower and Banc of California, as Lender 10-Q 001-38386 10.3 11/6/2024 10.37* Assumption Agreement and First Amendment to Loan and Security Agreement, dated as of December 6, 2024, by and among Cardlytics, Inc., as Borrower and Banc of California, as Lender 10.38*^ Assumption Agreement and Second Amendment to Loan and Security Agreement, dated as of January 27, 2025, by and among Cardlytics, Inc., as Borrower and Banc of California, as Lender 10.39 2024 Bonus Plan of the Registrant 19.1 Insider Trading Policy 21.1 Subsidiaries of the Registrant 10-Q 001-38386 21.1 8/14/2018 23.1* Consent of Deloitte & Touche LLP, independent registered public accounting firm 31.1* Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 31.2* Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to